A1AG1_HUMAN - dbPTM
A1AG1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID A1AG1_HUMAN
UniProt AC P02763
Protein Name Alpha-1-acid glycoprotein 1
Gene Name ORM1
Organism Homo sapiens (Human).
Sequence Length 201
Subcellular Localization Secreted.
Protein Description Functions as transport protein in the blood stream. Binds various ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability in the body. Appears to function in modulating the activity of the immune system during the acute-phase reaction..
Protein Sequence MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDQITGKWFYIASAFRNEEYNKSVQEIQATFFYFTPNKTEDTIFLREYQTRQDQCIYNTTYLNVQRENGTISRYVGGQEHFAHLLILRDTKTYMLAFDVNDEKNWGLSVYADKPETTKEQLGEFYEALDCLRIPKSDVVYTDWKKDKCEPLEKQHEKERKQEEGES
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
19Pyrrolidone_carboxylic_acidLLPLLEAQIPLCANL
HHHHHHCCCCCCCCC
28.58-
19Pyrrolidone_carboxylic_acidLLPLLEAQIPLCANL
HHHHHHCCCCCCCCC
28.584711474
19Pyrrolidone_carboxylic_acidLLPLLEAQIPLCANL
HHHHHHCCCCCCCCC
28.584711474
33N-linked_GlycosylationLVPVPITNATLDQIT
CCEEECCCCCHHHHC
31.4815084671
33N-linked_GlycosylationLVPVPITNATLDQIT
CCEEECCCCCHHHHC
31.481567356
56N-linked_GlycosylationAFRNEEYNKSVQEIQ
HHCCHHHHHHHHHCE
33.151567356
56N-linked_GlycosylationAFRNEEYNKSVQEIQ
HHCCHHHHHHHHHCE
33.1516335952
65PhosphorylationSVQEIQATFFYFTPN
HHHHCEEEEEEECCC
9.6325627689
72N-linked_GlycosylationTFFYFTPNKTEDTIF
EEEEECCCCCCCEEE
61.9018638581
72N-linked_GlycosylationTFFYFTPNKTEDTIF
EEEEECCCCCCCEEE
61.901567356
74PhosphorylationFYFTPNKTEDTIFLR
EEECCCCCCCEEEEE
45.8126657352
77PhosphorylationTPNKTEDTIFLREYQ
CCCCCCCEEEEEEEE
13.8526657352
83PhosphorylationDTIFLREYQTRQDQC
CEEEEEEEECCCCEE
14.5726657352
93N-linked_GlycosylationRQDQCIYNTTYLNVQ
CCCEEEEEEEEEEEE
13.1615084671
93N-linked_GlycosylationRQDQCIYNTTYLNVQ
CCCEEEEEEEEEEEE
13.1615084671
103N-linked_GlycosylationYLNVQRENGTISRYV
EEEEEEECCCEEEEE
55.9118638581
103N-linked_GlycosylationYLNVQRENGTISRYV
EEEEEEECCCEEEEE
55.911567356
109PhosphorylationENGTISRYVGGQEHF
ECCCEEEEECCHHHE
9.17-
109NitrationENGTISRYVGGQEHF
ECCCEEEEECCHHHE
9.17-
170GlycationLDCLRIPKSDVVYTD
HHHHCCCHHHCEEEC
57.84-
170AcetylationLDCLRIPKSDVVYTD
HHHHCCCHHHCEEEC
57.8427178108
175PhosphorylationIPKSDVVYTDWKKDK
CCHHHCEEECCCCCC
9.99-
179AcetylationDVVYTDWKKDKCEPL
HCEEECCCCCCCHHH
54.6327178108

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of A1AG1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of A1AG1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of A1AG1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
P63_HUMANTP63physical
21988832
CCGL_HUMANTMEM37physical
21988832
A1AG2_HUMANORM2physical
28514442
PTGDS_HUMANPTGDSphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of A1AG1_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Human urinary glycoproteomics; attachment site specific analysis ofN-and O-linked glycosylations by CID and ECD.";
Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
Mol. Cell. Proteomics 0:0-0(2011).
Cited for: GLYCOSYLATION AT ASN-33, STRUCTURE OF CARBOHYDRATES, AND MASSSPECTROMETRY.
"Enrichment of glycopeptides for glycan structure and attachment siteidentification.";
Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,Brinkmalm G., Larson G.;
Nat. Methods 6:809-811(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33 AND ASN-72, STRUCTUREOF CARBOHYDRATES, AND MASS SPECTROMETRY.
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93 AND ASN-103, AND MASSSPECTROMETRY.
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry.";
Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.;
J. Proteome Res. 5:1493-1503(2006).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93, AND MASS SPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72; ASN-93AND ASN-103, AND MASS SPECTROMETRY.
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry.";
Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
Proteomics 4:454-465(2004).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72; ASN-93AND ASN-103, AND MASS SPECTROMETRY.
"A proteomic analysis of human bile.";
Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.;
Mol. Cell. Proteomics 3:715-728(2004).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33 AND ASN-93, AND MASSSPECTROMETRY.
"A new strategy for identification of N-glycosylated proteins andunambiguous assignment of their glycosylation sites using HILICenrichment and partial deglycosylation.";
Hagglund P., Bunkenborg J., Elortza F., Jensen O.N., Roepstorff P.;
J. Proteome Res. 3:556-566(2004).
Cited for: GLYCOSYLATION AT ASN-33; ASN-72 AND ASN-93, AND MASS SPECTROMETRY.
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry.";
Zhang H., Li X.-J., Martin D.B., Aebersold R.;
Nat. Biotechnol. 21:660-666(2003).
Cited for: GLYCOSYLATION AT ASN-33.
"Analysis of the five glycosylation sites of human alpha 1-acidglycoprotein.";
Treuheit M.J., Costello C.E., Halsall H.B.;
Biochem. J. 283:105-112(1992).
Cited for: GLYCOSYLATION AT ASN-33; ASN-56; ASN-72; ASN-93 AND ASN-103.
"The disulfide bonds of alpha1-acid glycoprotein.";
Schmid K., Buergi W., Collins J.H., Nanno S.;
Biochemistry 13:2694-2697(1974).
Cited for: DISULFIDE BONDS.
Pyrrolidone carboxylic acid
ReferencePubMed
"Structure of alpha 1-acid glycoprotein. The complete amino acidsequence, multiple amino acid substitutions, and homology with theimmunoglobulins.";
Schmid K., Kaufmann H., Isemura S., Bauer F., Emura J., Motoyama T.,Ishiguro M., Nanno S.;
Biochemistry 12:2711-2724(1973).
Cited for: PROTEIN SEQUENCE OF 19-129.

TOP